Package 60505-6128-0

Brand: irinotecan hydrochloride

Generic: irinotecan hydrochloride
NDC Package

Package Facts

Identity

Package NDC 60505-6128-0
Digits Only 6050561280
Product NDC 60505-6128
Product ID 60505-6128_d2676b1a-30fb-456b-bb51-fb76fb64cf2d
Description

1 VIAL, SINGLE-USE in 1 CARTON (60505-6128-0) / 2 mL in 1 VIAL, SINGLE-USE

Marketing

Marketing Status
Marketed Since 2017-11-30
Brand irinotecan hydrochloride
Generic irinotecan hydrochloride
Sample Package No

Linked Drug Pages (1)

Irinotecan Hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "d2676b1a-30fb-456b-bb51-fb76fb64cf2d", "openfda": {"unii": ["042LAQ1IIS"], "rxcui": ["1726319", "1726324"], "spl_set_id": ["85ed6019-f462-4abe-a89e-ad991623c86d"], "manufacturer_name": ["Apotex Corp."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-USE in 1 CARTON (60505-6128-0)  / 2 mL in 1 VIAL, SINGLE-USE", "package_ndc": "60505-6128-0", "marketing_start_date": "20171130"}, {"sample": false, "description": "1 VIAL, SINGLE-USE in 1 CARTON (60505-6128-1)  / 5 mL in 1 VIAL, SINGLE-USE", "package_ndc": "60505-6128-1", "marketing_start_date": "20171130"}], "brand_name": "Irinotecan Hydrochloride", "product_id": "60505-6128_d2676b1a-30fb-456b-bb51-fb76fb64cf2d", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Topoisomerase Inhibitor [EPC]", "Topoisomerase Inhibitors [MoA]"], "product_ndc": "60505-6128", "generic_name": "Irinotecan Hydrochloride", "labeler_name": "Apotex Corp.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Irinotecan Hydrochloride", "active_ingredients": [{"name": "IRINOTECAN HYDROCHLORIDE", "strength": "20 mg/mL"}], "application_number": "ANDA203380", "marketing_category": "ANDA", "marketing_start_date": "20171130", "listing_expiration_date": "20261231"}